Matrix metalloproteinase 2 expression and survival of patients with osteosarcoma: a meta-analysis

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Tumor Biology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s13277-013-1116-1PMID 24037915
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A review of the association between osteosarcoma metastasis and protein translation.

  2012cited by this paper
• Matrix metalloproteinase 2 promotes cell growth and invasion in colorectal cancer.

  2011cited by this paper
• Current concepts on pathogenesis and biology of metastatic osteosarcoma tumors.

  2011cited by this paper
• Ewing's sarcoma.

  2010cited by this paper
• Matrix metalloproteinases: regulators of the tumor microenvironment.

  2010cited by this paper
• Recent advances in the molecular pathogenesis of Ewing's sarcoma

  2010cited by this paper
• Matrix Metalloproteinases 2, 7, 9 and Tissue Inhibitor of Matrix Metalloproteinase-1 in the Sera of Patients with Bone Tumors

  2010cited by this paper
• Association of Malignant Osteoblastoma Prognosis with Midkine,Survivin and MMP-2 Expression

  2010cited by this paper
• Osteosarcoma.

  2009cited by this paper
• Matrix metalloproteinase proteomics: substrates, targets, and therapy.

  2009cited by this paper
• Osteosarcoma treatment: state of the art

  2009cited by this paper
• Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches.

  2008cited by this paper
• Increased expression of membrane-type matrix metalloproteinase-1 is correlated with poor prognosis in patients with osteosarcoma.

  2006cited by this paper
• Surgical options for children with osteosarcoma.

  2005cited by this paper
• P53 as a prognostic marker for bladder cancer: a meta-analysis and review.

  2005cited by this paper
• Expression of membrane-type-1-matrix metalloproteinase and metalloproteinase-2 in nonsmall cell lung carcinomas

  2003cited by this paper
• Measuring inconsistency in meta-analyses

  2003cited by this paper
• Expression of membrane-type-1-matrix metalloproteinase and metalloproteinase-2 in nonsmall cell lung carcinomas.

  2002cited by this paper
• New functions for the matrix metalloproteinases in cancer progression

  2002cited by this paper
• Matrix metalloproteinases: biologic activity and clinical implications.

  2000cited by this paper
• Bias in meta-analysis detected by a simple, graphical test

  1997cited by this paper
• Meta-analysis in clinical trials.

  1986cited by this paper
• Statistical aspects of the analysis of data from retrospective studies of disease.

  1959cited by this paper

• Biomarkers of cellular senescence and risk of death in humans

  2023cites this paper
• The role of MT1-MMP in the progression and metastasis of osteosarcoma

  2022cites this paper
• The tumor suppressive role of TIMP3 in the human osteosarcoma cells.

  2021cites this paper
• Prognostic Role of Matrix Metalloproteinases in Cervical Cancer: A Meta-Analysis

  2021cites this paper
• Molecular docking of alkaloid compounds with the matrix metalloproteinase 2

  2021cites this paper
• Expression of CXCR4 and MMP-2 is associated with poor prognosis in patients with osteosarcoma.

  2020cites this paper
• Increased MMP2 contributes to the diagnosis and prognosis of lung cancer

  2020cites this paper
• Correlation between MMP2 expression in lung cancer tissues and clinical parameters: a retrospective clinical analysis

  2020cites this paper
• The tetraspanin CD81 mediates the growth and metastases of human osteosarcoma

  2019cites this paper
• The anti-neoplastic effect of doxycycline in osteosarcoma as a metalloproteinase (MMP) inhibitor: a systematic review

  2019cites this paper
• Osteosarcoma progression is associated with increased nuclear levels and transcriptional activity of activated β-Catenin

  2019cites this paper
• Role of miR‐142 in the pathogenesis of osteosarcoma and its potential as therapeutic approach

  2018cites this paper
• Amentoflavone Inhibits Metastatic Potential Through Suppression of ERK/NF-κB Activation in Osteosarcoma U2OS Cells.

  2017cites this paper
• Matrix metalloproteinase 9 expression and survival of patients with osteosarcoma: a meta‐analysis

  2017cites this paper
• Prognostic value of MMP-2 for patients with ovarian epithelial carcinoma: a systematic review and meta-analysis

  2017cites this paper
• Distribution and activity levels of matrix metalloproteinase 2 and 9 in canine and feline osteosarcoma.

  2016cites this paper
• TIMP3 regulates osteosarcoma cell migration, invasion, and chemotherapeutic resistances

  2016cites this paper
• Clinicopathological significance of matrix metalloproteinase 2 protein expression in patients with renal cell carcinoma: A case-control study and meta-analysis

  2016cites this paper
• Prognostic significance of serum lactate dehydrogenase levels in Ewing's sarcoma: A meta-analysis.

  2016cites this paper
• Paris saponin VII suppresses osteosarcoma cell migration and invasion by inhibiting MMP-2/9 production via the p38 MAPK signaling pathway

  2016cites this paper
• α-Mangostin suppresses 12-o-tetradecanoylphorbol-13- acetate-mediated matrix metalloproteinase-9 expression in human osteosarcoma cells U2OS

  2016cites this paper
• Questions about XY Wen et al. entitled “Matrix metalloproteinase 2 expression and survival of patients with osteosarcoma: a meta-analysis”

  2015cites this paper
• MiR-142 acts as a tumor suppressor in osteosarcoma cell lines by targeting Rac1.

  2015cites this paper
• Molecular docking and inhibition of matrix metalloproteinase-2 by novel difluorinatedbenzylidene curcumin analog.

  2015cites this paper
• Celecoxib inhibits cell growth and modulates the expression of matrix metalloproteinases in human osteosarcoma MG-63 cell line.

  2015cites this paper
• Matrix metalloproteinase variants associated with risk and clinical outcome of esophageal cancer.

  2015cites this paper
• Prognostic significance of serum lactate dehydrogenase level in osteosarcoma: a meta-analysis

  2014cites this paper
• Significance of MTA1 in the molecular characterization of osteosarcoma

  2014cites this paper
• Establishment and analysis of osteosarcoma cell sublines with different metastatic characteristics

  2014cites this paper
• Letter regarding Wen X.Y. et al. entitled “Matrix metalloproteinase 2 expression and survival of patients with osteosarcoma: a meta-analysis”

  2014cites this paper
• Cyr61 silencing reduces vascularization and dissemination of osteosarcoma tumors

  2014cites this paper
• Osteosarcoma: Diagnostic dilemmas in histopathology and prognostic factors

  2014cites this paper
• P16INK4a overexpression and survival in osteosarcoma patients: a meta analysis.

  2014cites this paper
• P 16 INK 4 a overexpression and survival in osteosarcoma patients : a meta analysis

  2014cites this paper